DP-3Ø5423-1
Commodity:
Soyabean / Soybeans
Traits:
Changes in metabolite content /production > Lipid and fatty acids > High oleic acid
Resistance to herbicides > Acetohydroxyacid synthase (AHAS)/Acetolactate synthase (ALS) inhibitors
Republic of Korea
Country profileName of Product Applicant:
DuPont (Korea) Inc.
Application Summary:
Sulfonylurea herbicide tolerance, an increased level of oleic acid and decreases in the level of linoleic acid
Authorization Date:
30/12/2010
Authorization Scope:
Food
Safety Assessment Summary:
Please see the link below(in Korean).
Detection Method:
Relevant Links:
Authorization expiration date, if any:
Relevant documents upload:
Indonesia
Country profileName of Product Applicant:
PT. DuPont Indonesia
Application Summary:
A genetically modified (GM) soybean event 305423 has been developed to be tolerant to sulfonylurea herbicides through the expression of gm-hra gene which produces modified acetolacetate synthase (ALS) enzyme and the soybean also has modified oil/fatty acid by blocking the formation of linoleic acid from oleic acid through silencing of gm-fad2-1 gene.
Authorization Date:
30/01/2017
Authorization Scope:
Food
Safety Assessment Summary:
Please see the attached documents (in Indonesian)
Detection Method:
Relevant Links:
Authorization expiration date, if any:
Relevant documents upload:
Philippines
Country profileName of Product Applicant:
Pioneer Hi-Bred
Application Summary:
Pioneer Hi-Bred Philippines, Inc. has developed a transgenic soybean product, Soybean 305423, that provides soybean seeds with increased levels of monounsaturated (oleic) fatty acid and decreased levels polyunsaturated fatty acids (linoleic and linolenic) and to a lesser extent palmitic acid.
The 305423 soybean has been produced by microprojectile bombardment with two linear DNA fragments containing the gm-fad2-1 and the gm-hra gene cassettes.
The gm-fad2-1 gene fragment is derived from the endogenous soybean FAD2-1 gene that encodes an omega-6 desaturase that converts oleic acid to linoleic acid. The gm-fad2-1 gene fragment does not encode a functional protein, instead its transcription acts to silence expression of the endogenous fad2-1 gene, resulting in an increased level of oleic acid and decreased levels of linoleic and linolenic acids in 305423 soybean seeds.
The gm-hra gene, which was used as a selectable marker, contains its gene fragments which encoded a modified version of acetolactate synthase (ALS) providing tolerance to ALS inhibiting classes of herbicides (sulfonylurea).
Authorization Date:
09/09/2013
Authorization Scope:
Food and feed
Safety Assessment Summary:
Pioneer Hi-Bred submitted an application to the Bureau of Plant Industry (BPI) requesting for biosafety permit under A.O. #8 for high oleic soybean, Soybean 305423.
Soybean 305423 has been evaluated according to BPI’s safety assessment by concerned agencies of the Department of Agriculture (DA): [(Bureau of Animal Industry (BAI and Bureau of Agriculture, Fisheries and Product Standards (BAFPS)] and a Scientific Technical Review Panel (STRP). The process involves an intensive analysis of the nature of the genetic modification together with a consideration of general safety issues, toxicological issues and nutritional issues associated with the modified soybean.
The petitioner/applicant published the said application in two widely circulated newspapers for public comment/review. BPI received no comment on the petition during the 30-day comment period.
Review of results of evaluation by the BPI Biotech Core Team in consultation with DA-Biotechnology Advisory Team (DA-BAT) completed the approval process.
Detection Method:
Relevant Links:
Authorization expiration date, if any:
Relevant documents upload:
Japan
Country profileName of Product Applicant:
DuPont K.K.
Application Summary:
DP-305423-1 has been genetically modified to produce seeds with an increased level of oleic acid, and to be high oleic acid and tolerant to herbicide acetolactate synthase inhibitor (gm-fad2-1, gm-hra, Glycine max (L.) Merr.).
Authorization Date:
30/06/2010
Authorization Scope:
Food and feed
Safety Assessment Summary:
Please see the links below (in Japanese).
Detection Method:
Relevant Links:
Authorization expiration date, if any:
Relevant documents upload:
Canada
Country profileName of Product Applicant:
Pioneer Hi-Bred International
Application Summary:
Soybean event 305423 was genetically modified using recombinant DNA techniques to reintroduce a partial sequence of the soybean microsomal omega-6 desaturase (gm-fad2-1) coding sequence into the genome. The inserted sequence is intended to silence the GM-FAD2-1 enzyme, a seed-specific fatty acid desaturase that converts oleic acid into linoleic acid by the addition of a second double bond at the omega-6 position, in order to generate the high oleic phenotype. Health Canada has previously approved high oleic acid soybean events G94-1, G94-19, and G168 (NF-55) for food use in October, 2000. The high oleic trait found in the above events was also achieved by silencing of the gm-fad2-1 gene. The Department has also approved several low linolenic acid soybean lines for food use (NF-62 on October 17, 2000; and NF-147 on October 5, 2006). However, these soybean lines were selected by conventional plant breeding methods, and do not exhibit the same high oleic fatty acid profiles. Health Canada also previously approved for food use the high oleic acid / low linolenic acid canola lines 45A37 and 46A40 (NF-21) on August 15, 1996. These canola lines are fad-2 gene mutants and exhibit similar oil profiles as the present soybean line.
The assessment conducted by Food Directorate evaluators determined: how soybean event 305423 was developed; how the composition and nutritional quality of soybean event 305423 compared to non-modified varieties; and what the potential is for event 305423 soybeans to be toxic or cause allergic reactions. Pioneer Hi-Bred Production has provided data which demonstrates that event 305423 soybeans are as safe and of the same nutritional quality as traditional soybean varieties used as food in Canada with the exception of significantly higher levels of oleic acid and significantly lower levels of linoleic, linolenic, and palmitic fatty acids.
The Food Program has a legislated responsibility for the pre-market assessment of novel foods and novel food ingredients as detailed in the Food and Drug Regulations (Division 28). Food use of soybean event 305423 is considered novel under the following part of the definition of novel foods:
"c) a food that is derived from a plant, animal or microorganism that has been genetically modified such that
(iii) one or more characteristics of the plant, animal or microorganism no longer fall within the anticipated range for that plant, animal or microorganism."
Authorization Date:
06/05/2009
Authorization Scope:
Food and feed
Safety Assessment Summary:
Please see decision document weblinks
Detection Method:
Authorization expiration date, if any:
Relevant documents upload:
Mexico
Country profileName of Product Applicant:
Híbridos Pioneer de México, S.A. de C.V.
Application Summary:
Authorization by COFEPRIS: 60
DP-305423-1 has been genetically modified to produce seeds with an increased level of oleic acid, and to be high oleic acid and tolerant to herbicide acetolactate synthase inhibitor (gm-fad2-1, gm-hra, Glycine max (L.) Merr.).
Authorization Date:
03/09/2008
Authorization Scope:
Food
Safety Assessment Summary:
UI OECD: DP-3Ø5423-1
During the risk assessment of this GMO based on existing knowledge to date, no toxic or allergic effects neither substantial nutritional changes are observed. The event is as safe as its conventional counterpart.
For more detail please find attached the risk assessment summary in this page.
Detection Method:
Relevant Links:
Authorization expiration date, if any:
Relevant documents upload:
New Zealand
Country profileName of Product Applicant:
Pioneer Hi-Bred International Inc.
Application Summary:
Soybean line DP-305423-1 (hereafter referred to as soybean 305423) has been genetically modified to produce seeds with an increased level of oleic acid. This modification results in concomitant decreases in the level of linoleic acid. Seeds of this high oleic acid soybean line are intended for use in the production of PLENISH™ high oleic acid soybean oil in an identity preserved production system. Many conventional cooking oils, including soybean, have poor oxidative stability due to naturally high levels of linoleic acid and thus require additional processing, such as chemical hydrogenation to stabilise them. This, in turn, leads to the undesirable formation of trans fats. The high oleic acid oil derived from soybean 305423 provides an alternative to partially hydrogenated oils.It would be used primarily to replace commercial frying oils used with french fries, potato chips, tortilla chips and other corn based snacks, commercially fried fish, and commercially fried chicken as well as oils used as a spray treatment on crackers, pretzels, and other grain snacks.The increased levels of oleic acid in soybean 305423 have been achieved throughthe introduction of a partial gene sequence (fragment) designed to decrease the expression of one of the endogenous soybean fatty acid desaturase genes (gm-fad2-12 that encodes microsomal ω-6 desaturase. The endogenous gm-fad 2-1 gene playsa major role in desaturation of storage lipids synthesised during the mid-maturation stages of seed development. More specifically, it is responsible for the conversion of oleic acid (18:1) to linoleic acid (18:2) which is the major unsaturated fatty acidpresent in soybean oil. The decrease in endogenous expression is achieved through a mechanism known as co-suppression. The presence of the introduced fragment of the fatty acid desaturase gene results in suppression of expression of the endogenous fatty acid desaturase gene, thus significantly reducing linoleic acid formation and leading to the accumulation of oleic acid. The high levels of oleic acid are confined largely to the seed, as this is primarily where the gm-fad2-1 gene is expressed. Fatty acid biosynthesis functions normally in other plant parts such as the leaves.Soybean 305423 also contains a complete gene sequence that encodes a modified version of the soybean acetolactate synthase (ALS)3 protein which confers adegree of tolerance to ALS-inhibiting herbicides. The gene is known asgm-hra. In soybean 305423 it is used as a marker gene in order to select potentialtransformants at the early stage of the transformation procedure and is not intended for agronomic use. No antibiotic-resistance marker genes are present in soybean 305423.
Authorization Date:
29/04/2010
Authorization Scope:
Food
Safety Assessment Summary:
No potential public health and safety concerns have been identified in the assessment of
high oleic acid soybean 305423. On the basis of the data provided in the present
Application, and other available information, food derived from soybean 305423 is
considered as safe for human consumption as food derived from conventional soybean
cultivars.
Detection Method:
Relevant Links:
Authorization expiration date, if any:
Relevant documents upload:
United States of America
Country profileName of Product Applicant:
Pioneer Hi-Bred
Application Summary:
Soybean
Trait 1 Added Protein: Microsomal omega-6 desaturase gene (FAD2-1) gene fragment
Source: Soybean
Intended Effect: Increased levels of monounsaturated fatty acid (oleic) and decreased levels of polyunsaturated fatty acids (linoleic and linolenic)
Authorization Date:
15/01/2009
Authorization Scope:
Food and feed
Safety Assessment Summary:
Please consult the FDA website links below.
Detection Method:
Relevant Links:
Authorization expiration date, if any:
Relevant documents upload:
Colombia
Country profileName of Product Applicant:
Dupont Colombia S.A
Application Summary:
Authorization of the genetically modified soy 3054238 which modifies quantity and quality of lipid/fatty acids
Authorization Date:
28/11/2016
Authorization Scope:
Food
Safety Assessment Summary:
Based on the risk assessment, it can be concluded that the event shows the same risks as its conventional counterpart. Therefore the National Technical Biosafety Committee for GMO use exclusively in Health and human consumption (CTNSalud) recommends its authorization.
Detection Method:
Relevant Links:
Authorization expiration date, if any:
Relevant documents upload:
European Union
Country profileName of Product Applicant:
Pioneer Overseas Corporation
Application Summary:
Genetically modified DP-3Ø5423-1 soybean has a reduced expression of the soybean enzyme omega-6 desaturase, which results in a high oleic acid and reduced linoleic acid profile, and expresses an optimized Glycine max-hra gene, which confers tolerance to acetolactate synthase-inhibiting herbicides.
Products:
1) Foods and food ingredients containing, consisting of, or produced from DP-3Ø5423-1 soybean2) Feed containing, consisting or produced from DP-3Ø5423-1 soybean3) Products other than food and feed containing or consisting of 3Ø5423-1 soybean for the same uses as any other soybean with the exception of cultivation
Authorization Date:
24/04/2015
Authorization Scope:
Food and feed
Safety Assessment Summary:
Please see the EU relevant links below.
Detection Method:
Method for detection: Event specific real-time PCR based method for the quantification of DP-3Ø5423-1 soybean;
Validated by the EU Reference Laboratory established under Regulation (EC) No 1829/2003.
Reference material: ERM-BF426 accessible via the Joint Research Centre (JRC) of the European Commission, the Institute for Reference Materials and Measurements (IRMM).
Relevant links are provided below.
Relevant Links:
Authorization expiration date, if any:
26/04/2025
Relevant documents upload:
Iran (Islamic Republic of)
Country profileName of Product Applicant:
Pioneer Hi-Bred
Application Summary:
The intended effect of the modification in 305423 soybean is to produce soybean seeds with increased levels of monounsaturated fatty acid (oleic) and decreased levels of polyunsaturated fatty acids (linoleic and linolenic). To accomplish this objective, Pioneer inserted a fragment of the soybean microsomal omega-6 desaturase gene (FAD2-1) into soybean. The fragment of the FAD2-1 gene does not code for a protein.Transcription of the gene fragment under the control of a seed-preferred KTi3 promoter acts to silence the expression of the endogenous soybean omega-6 desaturase, which results in an increased level of oleic acid and decreased levels of linoleic and linolenic acids in the soybean seed. A gene (gm-hra) encoding a modified version of the soybean acetolactate synthase (als gene) that confers tolerance to a sulfonylurea herbicide was used as a selectable marker for the transformation.
Authorization Date:
24/04/2018
Authorization Scope:
Food
Safety Assessment Summary:
Competent National Authority: Ministry of Health and Medical Education- Food & Drug Administration. Risk Assessment file is uploaded.
https://bch.cbd.int/en/database/RA/BCH-RA-IR-114064/2
Detection Method:
Relevant Links:
Authorization expiration date, if any:
Relevant documents upload:
Malaysia
Country profileName of Product Applicant:
Du Pont Production Agriscience (M) Sdn. Bhd.
Application Summary:
Please refer to the decision document of the National Biosafety Board
Authorization Date:
01/08/2017
Authorization Scope:
Food and feed
Safety Assessment Summary:
Please refer to the Risk Assessment Report
Detection Method:
Relevant Links:
Authorization expiration date, if any:
Thailand
Country profileName of Product Applicant:
Pioneer Hi-Bred (Thailand) Co., Ltd.
Application Summary:
Commodity: Soybean (Glycine max L.)
Soybean event DP-305423-1 has been genetically modified to silence the expression of the endogenous soybean omega-6 desaturase gene (FAD2-1) which results in an increased level of oleic acid and decreased levels of linoleic and linolenic acids in the soybean seed, and to expresses GM-HRA protein (modified version of the soybean acetolactate synthase) which confers tolerance to a sulfonylurea herbicide was used as a selectable marker enabling identification of transformed plant cells.
Authorization Date:
04/12/2022
Authorization Scope:
Food
Safety Assessment Summary:
The food safety assessment performed by the National Center for Genetic Engineering and Biotechnology (BIOTEC) as advisory and technical arm of Thai FDA. BIOTEC conduct food safety assessment according to codex guideline and based on the safety data and information provided by the applicant (as specified in Annex 2 attached to Notification of the Ministry of Public Health No.431). According to the existing scientific data and information available during the safety assessment, it is concluded that the soybean event DP-305423-1 is substantially equivalent to its conventional counterpart in terms of morphology, toxicity, allergenicity and nutrition except for the intended changes compositions and did not reveal other differences of any biological or nutritional significance.
Detection Method:
Relevant Links:
Authorization expiration date, if any:
Relevant documents upload:
Singapore
Country profileName of Product Applicant:
Dupont
Application Summary:
Apply for use as food or feed or for processing
Authorization Date:
09/03/2012
Authorization Scope:
Food and feed
Safety Assessment Summary:
Soybean 305423 (DP-305423-1) has been genetically modified with a partial gene sequence (fragment) designed to decrease the expression of the endogenous soybean fatty acid desaturase gene (gm-fad2-1). This leads to the production of seeds higher in oleic acid (C18:1) and correspondingly lower in linoleic acid (C18:2). Soybean 305423 also contains a modified version of a soybean acetolactate synthase (ALS) gene (gm-hra), conferring a degree of tolerance to the ALS-inhibiting class of herbicides (e.g. the sulfonylureas). Molecular analyses showed that there are 4 insertion sites at a single genetic locus. These sites contain multiple copies, both intact and truncated, of the gm-fad2-1 partial sequence and a single copy of the gm-hra gene. Breeding over three generations has confirmed stability of the introduced genetic elements and segregation data indicate their Mendelian inheritance. Soybean 305423 expresses one novel protein, GM-HRA, which is a modified version of the native ALS from soybean. The GM-HRA protein is non-toxic and non-allergenic to humans. Seeds from 305423 contain elevated levels of oleic acid and reduced levels of linoleic acid, when compared to conventional soybean, but is equivalent to other commercially available soybean varieties in terms of its safety and nutritional composition.
Detection Method:
Relevant Links:
Authorization expiration date, if any:
Relevant documents upload:
South Africa
Country profileName of Product Applicant:
Du Pont Pioneer
Application Summary:
The GM soybean 305423 is produced by microparticle bombardment. The soybean expresses gm-fad2-1 and gm-hra proteins which alters the oleic acid and confers tolerance to herbicide products containing sulfonylurea.
Authorization Date:
26/09/2011
Authorization Scope:
Food and feed
Safety Assessment Summary:
The GM soybean 305423 has been assessed in terms of the Genetically Modified Organisms Act, 1997 by the Advisory Committee a scientific panel and the Executive Council an intergovernmental decision making body. The assessment considered amongst others the following: The source of the gene, nature of host organism, protein expression, toxicology and allergenicity issues.
Detection Method:
Relevant Links:
Authorization expiration date, if any:
Relevant documents upload:
Australia
Country profileName of Product Applicant:
Pioneer Hi-Bred International Inc.
Application Summary:
Soybean line DP-305423-1 (hereafter referred to as soybean 305423) has been genetically modified to produce seeds with an increased level of oleic acid. This modification results in concomitant decreases in the level of linoleic acid. Seeds of this high oleic acid soybean line are intended for use in the production of PLENISH™ high oleic acid soybean oil in an identity preserved production system. Many conventional cooking oils, including soybean, have poor oxidative stability due to naturally high levels of linoleic acid and thus require additional processing, such as chemical hydrogenation to stabilise them. This, in turn, leads to the undesirable formation of trans fats. The high oleic acid oil derived from soybean 305423 provides an alternative to partially hydrogenated oils.
It would be used primarily to replace commercial frying oils used with french fries, potato chips, tortilla chips and other corn based snacks, commercially fried fish, and commercially fried chicken as well as oils used as a spray treatment on crackers, pretzels, and other grain snacks.
The increased levels of oleic acid in soybean 305423 have been achieved through
the introduction of a partial gene sequence (fragment) designed to decrease the expression of one of the endogenous soybean fatty acid desaturase genes (gm-fad2-12 that encodes microsomal ω-6 desaturase. The endogenous gm-fad 2-1 gene plays
a major role in desaturation of storage lipids synthesised during the mid-maturation stages of seed development. More specifically, it is responsible for the conversion of oleic acid (18:1) to linoleic acid (18:2) which is the major unsaturated fatty acid
present in soybean oil.
The decrease in endogenous expression is achieved through a mechanism known as co-suppression. The presence of the introduced fragment of the fatty acid desaturase gene results in suppression of expression of the endogenous fatty acid desaturase gene, thus significantly reducing linoleic acid formation and leading to the accumulation of oleic acid. The high levels of oleic acid are confined largely to the seed, as this is primarily where the gm-fad2-1 gene is expressed. Fatty acid biosynthesis functions normally in other plant parts such as the leaves.
Soybean 305423 also contains a complete gene sequence that encodes a modified version of the soybean acetolactate synthase (ALS)3 protein which confers a
degree of tolerance to ALS-inhibiting herbicides. The gene is known as
gm-hra. In soybean 305423 it is used as a marker gene in order to select potential
transformants at the early stage of the transformation procedure and is not intended for agronomic use. No antibiotic-resistance marker genes are present in soybean 305423.
Authorization Date:
18/02/2010
Authorization Scope:
Food
Safety Assessment Summary:
Detection Method:
Relevant Links:
Authorization expiration date, if any:
Relevant documents upload: